Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupropion and Varenicline for Smoking Cessation and Emotional Reactivity
NCT00507728Phase 3Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Dec 2005
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of varenicline, bupropion in Tobacco Use Disorder (TUD), sponsored by University of Texas MD Anderson Cancer Center. Started Dec 2005; status: completed.
02
Drugs
vareniclinebupropion
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT00507728.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00507728.